Coblopasvir hydrochloride(1966138-53-3)
- Name: Coblopasvir hydrochloride
- Synonyms:Carbamic acid, N-[(1S)-1-[[(2S)-2-[5-[4-[7-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-imidazol-5-yl]-1,3-benzodioxol-4-yl]phenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester, hydrochloride (1:2);Coblopasvir dihydrochloride;HCV Protease,inhibit,Coblopasvir dihydrochloride,KW136,Coblopasvir,HCV,chronic hepatitis C virus infection,pangenotypic regimen,Hepatitis C virus,KW-136,NS5A,KW 136,Inhibitor;Coblopasvir dihydrochloride, 10 mM in DMSO
- Molecular Formula:C41H51ClN8O8
- Molecular Weight:819.36
- CAS Registry Number:1966138-53-3
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1965329-42-3/(S)-PraMipexole-d5 Dihydrochloride
- 1965330-55-5/9-mesityl-2,7-dimethoxy-10-phenylacridin-10-ium tetrafluoroborate
- 1965330-57-7/9-mesityl-3,6-dimethoxy-10-phenylacridin-10-ium tetrafluoroborate
- 1965330-59-9/10-(3,5-Dimethoxyphenyl)-9-mesityl-1,3,6,8-tetramethoxyacridin-10-ium tetrafluoroborate >=95%
- 1965330-61-3/9-mesityl-1,3,6,8-tetramethoxy-10-phenylacridin-10-ium tetrafluoroborate
- 1965335-70-9/Oxazole, 2-[2-[(R)-[4-(1,1-dimethylethyl)phenyl]sulfinyl]phenyl]-4,5-dihydro-4-phenyl-, (4S)-
- 196-56-5/4H-Benzo[j]dinaphtho[1,8-ab:2',3'-f][4,7]phenanthroline
- 1965764-77-5/Benzenamine, 4-(2,4-dimethyl-1-piperazinyl)-3-(trifluoromethyl)-
- 196597-11-2/5-Bromo-4,4,5,5-tetrafluoropent-2-en-1-ol
- 196597-95-2/N-[2-(6,7-dihydroxyindan-1-yl)ethyl]butyramide
- 196597-99-6/N-[2-(7-amino-6-methoxyindan-1-yl)ethyl]acetamide
- 196598-23-9/N-[2-(4-allyl-2,3-dihydro-5-hydroxyindol-3-yl)ethyl]butyramide
- 196599-80-1/1,2-Bis(4-methoxyphenyl)-2-oxoethyl Cyclohexylcarbamate
- 196601-66-8/196601-66-8
- 196601-98-6/4H-1-Benzopyran-4-one, 2-[2-[[(4-O-α-D-glucopyranosyl-β-D-glucopyranosyl)oxy]methyl]-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-
- 196603-78-8/4-chloro-6,7-dimethoxyquinazoline HCL
- 196610-37-4/Phenol, 4-fluoro-3-nitro-, acetate (ester) (9CI)
- 1966123-30-7/tert-Butyl 2-(3-fluoro-2-nitrophenoxy)acetate
- 196613-65-7/cis-3-Methyl-piperidin-4-ylamine
- 1966138-53-3/Coblopasvir hydrochloride
- 1966148-50-4/7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7-(phenylmethyl)-
- 1966153-13-8/Hexanoic acid, 6-[[(2,4-dimethylphenyl)methyl]thio]-
- 1966153-17-2/C-Type Natriuretic Peptide (1-22)
- 1966153-30-9/2,2-Bis(hydroxmethyl)-1,3-propanediol 3-mercaptopropyl ethers
- 1966183-72-1/Giffonin R
- 196618-71-0/2-[2-(aminomethyl)bicyclo[2.2.1]heptan-2-yl]acetic acid hydrochloride
- 1966890-13-0/4-Carboxy-2,5-difluorophenylboronic acid
- 1966890-94-7/3-Quinolinecarboxylic acid, 2-amino-6-chloro-, methyl ester
- 1966893-62-8/2-Propenamide, 2-cyano-3-(1-methyl-1H-indol-3-yl)-, (2E)-
- 1966921-94-7/(S)-2-(3-methyl-1-((3-methyl-1,2,4-oxadiazol-5-yl)methyl)-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)propanoic acid